Lion's Mane (Hericium erinaceus) vs Sabroxy (Oroxylum indicum)

Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.

Lion's Mane (Hericium erinaceus)Sabroxy (Oroxylum indicum)
CategoryNootropicsNootropics
Standard Dose500-3000 mg/day of fruiting body extract (standardized to >30% polysaccharides) or 1000-3000 mg/day of mycelium extract (erinacine-enriched)
TimingMorning or split morning/afternoon. With or without food. Effects are cumulative — expect 2-4 weeks before noticeable cognitive benefit.
Cycle DurationOngoing; no cycling strictly required, though some users cycle 8 weeks on, 2 weeks off
Evidence Levelmoderate_humanEmerging

Mechanism

Contains hericenones (fruiting body) and erinacines (mycelium) that stimulate nerve growth factor (NGF) synthesis in glial cells via activation of the JNK pathway. Erinacines cross the blood-brain barrier via passive diffusion and act as potent neurotrophin-stimulating compounds, activating the TrkA receptor and downstream ERK1/2 signaling cascades to promote hippocampal neurogenesis and synaptic plasticity. Also demonstrates anti-inflammatory activity through suppression of NF-kB and upregulation of BDNF expression.

Standard Dosing

500-3000 mg/day of fruiting body extract (standardized to >30% polysaccharides) or 1000-3000 mg/day of mycelium extract (erinacine-enriched)

Timing

Morning or split morning/afternoon. With or without food. Effects are cumulative — expect 2-4 weeks before noticeable cognitive benefit.

Cycle Duration

Ongoing; no cycling strictly required, though some users cycle 8 weeks on, 2 weeks off

Side Effects

  • GI discomfort
  • Skin rash (rare, allergic)
  • Headache
  • Dizziness (uncommon)

Contraindications

  • Known mushroom allergy
  • Pending surgery (discontinue 2 weeks prior due to antiplatelet effects)
  • Active autoimmune conditions (theoretical concern due to immune stimulation)

Best Stacking Partners

CDP-CholineBacopa MonnieriPiracetamPramiracetamOmega-3 (DHA)

Mechanism

Contains oroxylin A — a flavonoid that inhibits PDE (phosphodiesterase), increases BDNF, and modulates dopamine signaling. Enhances focus and motivation without stimulant side effects. Also acts as a mild MAO-B inhibitor, preserving dopamine levels.

Contraindications

  • Concurrent MAO inhibitors

Not sure which is right for you?

Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.

Get Your Free Protocol →or take the assessment →